SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-9247"
 

Search: onr:"swepub:oai:DiVA.org:umu-9247" > Family history of c...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma

Andersson, Anne, 1966- (author)
Umeå universitet,Onkologi
Enblad, Gunilla (author)
Uppsala universitet,Enheten för onkologi
Tavelin, Björn (author)
Umeå universitet,Onkologi
show more...
Björkholm, Magnus (author)
Karolinska Institutet
Linderoth, Johan (author)
Lund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine
Lagerlöf, I (author)
Merup, Mats (author)
Karolinska Institutet
Sender, Mark (author)
Malmer, Beatrice (author)
Umeå universitet,Onkologi
show less...
 (creator_code:org_t)
2008-02-12
2008
English.
In: British Journal of Cancer. - : Springer Science and Business Media LLC. - 0007-0920 .- 1532-1827. ; 98:5, s. 1001-1005
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • This study estimated the risk of second primary malignancies after Hodgkin's lymphoma (HL) in relation to family history of cancer, age at diagnosis and latency, among 6946 patients treated for HL in Sweden in 1965–1995 identified through the Swedish Cancer Register (SCR). First-degree relatives (FDRs) to the HL patients and their malignancies were then ascertained together with their malignancies through the Multi-Generation Registry and SCR. The HL patient cohort was stratified on the number of FDRs with cancer, and standardised incidence ratios (SIRs) of developing SM were analysed. In the HL cohort, 781 SM were observed 1 year or longer after HL diagnosis. The risk for developing SM increased with the number of FDRs with cancer, SIRs being 2.26, 3.01, and 3.45 with 0, 1, or ≥2 FDRs with cancer, respectively. Hodgkin's lymphoma long-term survivors treated at a young age with a family history of cancer carry an increased risk for developing SM and may represent a subgroup where standardised screening for the most common cancer sites could be offered in a stringent surveillance programme.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

late effect
radiotherapy
second malignancy
cohort
Oncology
Onkologi
onkologi
Oncology
cohort
second malignancy
late effect
radiotherapy
MEDICINE

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view